Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation

Marta Peña, Maria Queralt Salas, Alberto Mussetti, Gabriel Moreno-Gonzalez, Anna Bosch, Beatriz Patiño, Laura Jiménez, Meriem Kara, Rocío Parody, Anna Sureda

Blood Adv (2021) 5 (17): 3418–3426.

https://doi.org/10.1182/bloodadvances.2021004812

Published: 2021

Includes: Supplemental data

Journal Articles

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Najla El Jurdi, Ahmad Rayes, Margaret L. MacMillan, Shernan G. Holtan, Todd E. DeFor, Judith Witte, Mukta Arora, Jo-Anne Young, Daniel J. Weisdorf

Blood Adv (2021) 5 (5): 1352–1359.

https://doi.org/10.1182/bloodadvances.2020003937

Published: 2021

Includes: Supplemental data

Journal Articles

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Blood Adv (2021) 5 (5): 1199–1208.

https://doi.org/10.1182/bloodadvances.2020003739

Published: 2021

Includes: Supplemental data

Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Blood Adv (2021) 5 (5): 1154–1163.

https://doi.org/10.1182/bloodadvances.2020003779

Published: 2021

Journal Articles

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Suhag Parikh, Joel A. Brochstein, Einat Galamidi, Aurélie Schwarzbach, Joanne Kurtzberg

Blood Adv (2021) 5 (3): 843–852.

https://doi.org/10.1182/bloodadvances.2020003248

Published: 2021

Includes: Supplemental data

Journal Articles

Naive T-cell depletion in stem cell transplantation

Marie Bleakley

Blood Adv (2020) 4 (19): 4980.

https://doi.org/10.1182/bloodadvances.2020001888

Published: 2020

Includes: Supplemental data

Journal Articles

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Wen-Kai Weng, Sally Arai, Andrew Rezvani, Laura Johnston, Robert Lowsky, David Miklos, Judith Shizuru, Lori Muffly, Everett Meyer, Robert S. Negrin, Erica Wang, Timothy Almazan, Lynn Million, Michael Khodadoust, Shufeng Li, Richard T. Hoppe, Youn H. Kim

Blood Adv (2020) 4 (18): 4474–4482.

https://doi.org/10.1182/bloodadvances.2020001627

Published: 2020

Journal Articles

Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD

Eleonora Latis, David Michonneau, Claire Leloup, Hugo Varet, Régis Peffault de Latour, CRYOSTEM Consortium, Elisabetta Bianchi, Gérard Socié, Lars Rogge

Blood Adv (2020) 4 (16): 3927–3942.

https://doi.org/10.1182/bloodadvances.2019001032

Published: 2020

Includes: Supplemental data

Journal Articles

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Alexander Ngwube, Niketa Shah, Kamar Godder, David Jacobsohn, Monica L. Hulbert, Shalini Shenoy

Blood Adv (2020) 4 (16): 3894–3899.

https://doi.org/10.1182/bloodadvances.2020002236

Published: 2020

Journal Articles

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Blood Adv (2020) 4 (16): 3913–3925.

https://doi.org/10.1182/bloodadvances.2020001648

Published: 2020

Includes: Supplemental data

Journal Articles

The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease

Robert Zeiser, Gérard Socié

Blood Adv (2020) 4 (15): 3789–3794.

https://doi.org/10.1182/bloodadvances.2020002097

Published: 2020

Journal Articles

Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality

Celalettin Ustun, Todd E. DeFor, Fatma K. Karadag, Hyun Don Yun, Sunita Nathan, Claudio G. Brunstein, Bruce R. Blazar, Daniel J. Weisdorf, Shernan G. Holtan, Khalid Amin

Blood Adv (2020) 4 (10): 2317–2324.

https://doi.org/10.1182/bloodadvances.2020001793

Published: 2020

Journal Articles

Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity

Mathilde Payen, Ioannis Nicolis, Marie Robin, David Michonneau, Johanne Delannoye, Camille Mayeur, Nathalie Kapel, Béatrice Berçot, Marie-José Butel, Jérôme Le Goff, Gérard Socié, Clotilde Rousseau

Blood Adv (2020) 4 (9): 1824–1832.

https://doi.org/10.1182/bloodadvances.2020001531

Published: 2020

Includes: Supplemental data

Journal Articles

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Amy E. DeZern, Marianna L. Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Javier Bolaños-Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky

Blood Adv (2020) 4 (8): 1770–1779.

https://doi.org/10.1182/bloodadvances.2020001729

Published: 2020

Includes: Supplemental data

Journal Articles

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael C. Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael Pratta, Miguel-Angel Perales, Yi-Bin Chen, Gabrielle Meyers, John F. DiPersio

Blood Adv (2020) 4 (8): 1656–1669.

https://doi.org/10.1182/bloodadvances.2019001043

Published: 2020

Includes: Supplemental data

Journal Articles

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor

Blood Adv (2020) 4 (7): 1284–1295.

https://doi.org/10.1182/bloodadvances.2019001259

Published: 2020

Includes: Supplemental data

Journal Articles

Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma

Blood Adv (2020) 4 (7): 1242–1249.

https://doi.org/10.1182/bloodadvances.2019001336

Published: 2020

Journal Articles

Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation

Hidekazu Itamura, Takero Shindo, Satoshi Yoshioka, Takayuki Ishikawa, Shinya Kimura

Blood Adv (2020) 4 (4): 667–671.

https://doi.org/10.1182/bloodadvances.2019000343

Published: 2020

Includes: Supplemental data

Journal Articles

The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

Blood Adv (2019) 3 (23): 4034–4042.

https://doi.org/10.1182/bloodadvances.2019000791

Published: 2019

Includes: Supplemental data

Journal Articles

Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation

Yasuyuki Arai, Tadakazu Kondo, Kyoko Fuse, Yasuhiko Shibasaki, Masayoshi Masuko, Junichi Sugita, Takanori Teshima, Naoyuki Uchida, Takahiro Fukuda, Kazuhiko Kakihana, Yukiyasu Ozawa, Tetsuya Eto, Masatsugu Tanaka, Kazuhiro Ikegame, Takehiko Mori, Koji Iwato, Tatsuo Ichinohe, Yoshinobu Kanda, Yoshiko Atsuta

Blood Adv (2019) 3 (22): 3626–3634.

https://doi.org/10.1182/bloodadvances.2019000934

Published: 2019

Includes: Supplemental data

NARROW

Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Naive T-cell depletion in stem cell transplantation

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease

Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality

Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor

Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma

Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation

The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only